{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:10:30Z","timestamp":1789567830105,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.044","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T01:06:42Z","timestamp":1708218402000},"page":"1873-1877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lassa fever vaccine use cases and demand: Perspectives from select West African experts"],"prefix":"10.1016","volume":"42","author":[{"given":"Lassan\u00e9","family":"Kabor\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Hausdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.044_b0005","unstructured":"World Health Organization. Lassa Fever. https:\/\/www.who.int\/health-topics\/lassa-fever#tab=tab_1."},{"key":"10.1016\/j.vaccine.2024.02.044_b0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever \u2014 the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.02.044_b0015","unstructured":"Dan-Nwafor, Chioma. Overview of Lassa fever epidemiology and current surveillance systems in Nigeria. https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/day1_session1_5_chioma-dannwafor_lassa-vaccine-meeting_nigeria.pdf?sfvrsn=64f0feee_3 (2022)."},{"key":"10.1016\/j.vaccine.2024.02.044_b0020","doi-asserted-by":"crossref","first-page":"e001116","DOI":"10.1136\/bmjgh-2018-001116","article-title":"Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings","volume":"4","author":"Mazzola","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2024.02.044_b0025","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2214-109X(20)30518-0","article-title":"Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study","volume":"9","author":"Duvignaud","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.02.044_b0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/v15010146","article-title":"Combating lassa fever in west african sub-region: progress, challenges, and future perspectives","volume":"15","author":"Aloke","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.02.044_b0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/trstmh\/traa011","article-title":"Lassa fever in pregnancy: a systematic review and meta-analysis","volume":"114","author":"Kayem","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.02.044_b0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tmi.13876","article-title":"Lassa fever vaccine candidates: a scoping review of vaccine clinical trials","volume":"28","author":"Sulis","year":"2023","journal-title":"Tropical Med Int Health"},{"key":"10.1016\/j.vaccine.2024.02.044_b0045","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1016\/j.vaccine.2019.09.009","article-title":"UK vaccines network: mapping priority pathogens of epidemic potential and vaccine pipeline developments","volume":"37","author":"Noad","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.044_b0050","unstructured":"World Health Organization. An R&D Blueprint for Action to Prevent Epidemics: Plan of Action. https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/an-randd-blueprint-for-action-to-prevent-epidemics.pdf?sfvrsn=f890ab4e_1 (2016)."},{"key":"10.1016\/j.vaccine.2024.02.044_b0055","unstructured":"World Health Organization. WHO Target Product Profile for Lassa virus Vaccine. https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/lassavirusvaccinetpp.pdf?sfvrsn=e6237a1_3&download=true (2017)."},{"key":"10.1016\/j.vaccine.2024.02.044_b0060","unstructured":"CEPI. Largest-ever Lassa fever research programme launches in West Africa. https:\/\/cepi.net\/news_cepi\/largest-ever-lassa-fever-research-programme-launches-in-west-africa\/?swcfpc=1 (2020)."},{"key":"10.1016\/j.vaccine.2024.02.044_b0065","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2022.09.046","article-title":"Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5\u201311-year-olds in the United States","volume":"40","author":"Romer","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.044_b0070","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/S2214-109X(21)00512-X","article-title":"Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories","volume":"10","author":"Shet","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.02.044_b0075","unstructured":"United Nations Department of Economic and Social Affairs & Population Division. World Population Prospects 2022."},{"key":"10.1016\/j.vaccine.2024.02.044_b0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4269\/ajtmh.20-0773","article-title":"Lassa fever among children in Eastern Province, Sierra Leone: a 7-year Retrospective Analysis (2012\u20132018)","volume":"104","author":"Samuels","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.02.044_b0085","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3201\/eid2508.181299","article-title":"Retrospective Cohort study of lassa fever in pregnancy","volume":"25","author":"Okogbenin","year":"2019","journal-title":"Southern Nigeria Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.044_b0090","doi-asserted-by":"crossref","unstructured":"Orji M-L et al. Prevalence, Pattern and Outcome of Pediatric Lassa Fever Disease (LFD) in a Tertiary Hospital, Southeast Nigeria. https:\/\/www.preprints.org\/manuscript\/202005.0269\/v1 (2020) doi:10.20944\/preprints202005.0269.v1.","DOI":"10.20944\/preprints202005.0269.v1"},{"key":"10.1016\/j.vaccine.2024.02.044_b0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","article-title":"Ribavirin for the treatment of Lassa fever: a systematic review and meta-analysis","volume":"87","author":"Eberhardt","year":"2019","journal-title":"Int J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T16:49:28Z","timestamp":1728838168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24002032"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lassa fever vaccine use cases and demand: Perspectives from select West African experts","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}